Why the study?
Many emerging load-sensitive biomarkers warranting consideration for monitoring athlete training load have not been extensively studied, and their measurement remains costly and inconvenient for practitioners.
Emerging blood-based biomarkers show promise for monitoring athlete workload, but require methodological advances like point-of-care devices for practical application.
Hypothesis-generating for load-sensitive biomarkers in athletes; prospective validation required before clinical adoption.
At present, various blood-based biomarkers have found their applications in the field of sports medicine. This current opinion addresses biomarkers that warrant consideration in future research for monitoring the athlete training load. In this regard, we identified a variety of emerging load-sensitive biomarkers, e.g., cytokines (such as IL-6), chaperones (such as heat shock proteins) or enzymes (such as myeloperoxidase) that could improve future athlete load monitoring as they have shown meaningful increases in acute and chronic exercise settings. In some cases, they have even been linked to training status or performance characteristics. However, many of these markers have not been extensively studied and the cost and effort of measuring these parameters are still high, making them inconvenient for practitioners so far. We therefore outline strategies to improve knowledge of acute and chronic biomarker responses, including ideas for standardized study settings. In addition, we emphasize the need for methodological advances such as the development of minimally invasive point-of-care devices as well as statistical aspects related to the evaluation of these monitoring tools to make biomarkers suitable for regular load monitoring.
No takes yet. Share an insight, caveat, or question.
Haller et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: